沈阳芯源微电子设备股份有限公司 执行委员会议事规则 第一章 总则 第一条 为进一步完善公司治理，推动企业发展战略和经营目标的有效实现， 规范运营，根据《沈阳芯源微电子设备股份有限公司章程》（以下简称"《公司 章程》"）规定，公司设立执行委员会（以下简称"执委会"），对董事会负责。 依据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理 准则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公 司自律监管指引第 1 号——规范运作》《公司章程》及公司运营管理的有关规定， 制订本规则。 第二条 本规则是执委会的行为准则，适用于执委会全体委员。 第二章 人员组成 第八条 执委会负责战略的执行和日常经营活动，对董事会负责，并在董事 会授权范围内行使职权，向董事会报告工作，主要职责权限包括： （一）执行公司股东会、董事会的决议，负责落实公司经营目标和战略项目； 第九条 董事会对执委会进行审批权授权的范围为：执委会每年度有权对以 下额度的交易事项做出决议，交易事项包括： （一）主业投资； 第三条 执委会成员是公司的高级管理人员，从公司非独立董事、总裁、副 总裁、董事会秘书、财务总监等人员中产生。 ...

沈阳芯源微电子设备股份有限公司 执行委员会主席工作细则 第一章 总则 第一条 为进一步完善公司治理，推动企业发展战略和经营目标的有效实现， 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准则》 《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》《沈阳芯源微电子设备股份有限公司章程》《沈阳 芯源微电子设备股份有限公司执行委员会议事规则》等有关规定，制定本细则。 第二条 执行委员会（以下简称"执委会"）主席主持公司生产经营管理工作， 组织实施董事会和执委会批准的决议，向董事会报告，对董事会负责。 第二章 执委会主席的任职资格与任免程序 第三条 执委会主席任职资格应当具备下列条件： （二）因贪污、贿赂、侵占财产、挪用财产罪或者破坏社会经济秩序，被判 处刑罚，或者因犯罪被剥夺政治权利，执行期满未逾五年，被宣告缓刑的，自缓 刑考验期满之日起未逾二年； 1 （三）担任破产清算的公司、企业的董事或者厂长、经理、并对该公司、企 业的破产负有个人责任的，自该公司破产清算完结之日起未逾三年； （一）具有较丰富的经济理论知识、管理知识及实践经验，具有较强的经 ...

证券代码：688037 证券简称：芯源微 公告编号：2025-056 特此公告。 沈阳芯源微电子设备股份有限公司董事会 2025 年 8 月 5 日 沈阳芯源微电子设备股份有限公司（以下简称"公司"）于 2025 年 8 月 4 日召开第三届董事会第二次会议，审议通过了《关于制定部分内部治理制度的议 案》。 根据《沈阳芯源微电子设备股份有限公司章程》的有关规定，公司设立执行 委员会，结合公司运营管理的有关规定，制定《沈阳芯源微电子设备股份有限公 司执行委员会议事规则》《沈阳芯源微电子设备股份有限公司执行委员会主席工 作细则》制度。 上述制度将于同日在上海证券交易所网站（www.sse.com.cn）予以披露。 沈阳芯源微电子设备股份有限公司 关于制定部分内部治理制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 ...

● 需要提请投资者注意的其他事项：无 一、增加日常关联交易基本情况 （一）增加日常关联交易履行的审议程序 证券代码：688037 证券简称：芯源微 公告编号：2025-055 沈阳芯源微电子设备股份有限公司 关于增加 2025 年度日常关联交易额度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 是否需要提交股东会审议：是 ● 日常关联交易对上市公司的影响：沈阳芯源微电子设备股份有限公司（以 下简称"公司"）与关联方发生的日常关联交易遵循公允、合理的原则，不存在 损害公司及全体股东特别是中小股东利益的行为，不会对关联方形成依赖，不会 影响公司独立性。 公司于 2025 年 8 月 4 日召开第三届董事会第二次会议，审议通过了《关于 增加 2025 年度日常关联交易额度的议案》，本次增加 2025 年度日常关联交易额 度 29,800.00 万元人民币。出席会议的非关联董事一致同意该议案，审议程序符 合相关法律法规的规定。本次增加日常关联交易额度事项尚需提交股东会审议。 公司召开了第三届董事会独立董 ...

证券代码：688037 证券简称：芯源微 公告编号：2025-057 沈阳芯源微电子设备股份有限公司 关于召开2025年第三次临时股东会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 （三） 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 （四） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 8 月 21 日 14 点 00 分 召开地点：辽宁省沈阳市浑南区彩云路 1 号沈阳芯源微电子设备股份有限公 司会议室 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东会类型和届次 2025年第三次临时股东会 （二） 股东会召集人：董事会 （五） 网络投票的系统、起止日期和投票时间 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 8 月 21 日 至2025 年 8 月 21 日 股东会召开日期：2025年8月21日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会 ...

Group 1 - The core viewpoint of the news is that ChipSource Microelectronics (芯源微) has experienced a decline in stock price and significant changes in its financial performance as of the first quarter of 2025 [1][3] - As of August 1, 2025, ChipSource Microelectronics' stock closed at 111.7 yuan, down 2.03%, with a trading volume of 32,500 lots and a transaction amount of 366 million yuan [1] - The company reported total revenue of 275 million yuan for the first quarter of 2025, representing a year-on-year growth of 12.74%, while net profit attributable to shareholders decreased by 70.89% to 4.66 million yuan [1] Group 2 - The company has a current ratio of 2.615 and a quick ratio of 1.410, indicating a strong liquidity position [1] - ChipSource Microelectronics has a debt-to-asset ratio of 50.24%, suggesting a moderate level of financial leverage [1] - The company has made investments in 6 enterprises and has participated in 322 bidding projects, showcasing its active engagement in the market [2]

Core Viewpoint - The semiconductor industry in China is transitioning from a global cooperative model to a regional strategic industry due to geopolitical factors, with significant growth in domestic wafer production capacity expected in the coming years [2][3]. Group 1: Market Trends - By 2024, China's mainland wafer production capacity is projected to account for nearly 25% of the global total, increasing to 31% by 2029, indicating a strong demand signal for local semiconductor equipment manufacturers [2]. - The equipment market size for wafer fabrication in mainland China is expected to reach $41.2 billion in 2024, leading other regions globally. However, a decline of 5% to $39 billion is anticipated in 2025 due to prior expansions and equipment stockpiling [2]. Group 2: Competitive Landscape - The impressive performance of equipment manufacturers in mainland China is attributed to their enhanced technological competitiveness and market development capabilities, supported by strong backing from the government and clients [3]. Group 3: Industry Players - A detailed table lists various companies involved in different process nodes, highlighting key players in the semiconductor equipment sector, such as North Huachuang, SMIC, and others, across various technologies [4].

Group 1 - A total of 12 stocks received buy ratings from institutions today, with Baolingbao, Puluo Pharmaceutical, and Xinyuanwei being newly covered by institutions [1] - Among the stocks rated, the average increase was 1.14%, outperforming the Shanghai Composite Index, with notable gainers including Xinyuanwei, Shantui, and Hanyi, which rose by 5.56%, 4.41%, and 4.09% respectively [1] - The stocks with the largest declines included Jinbo Biological, Baofeng Energy, and Miao Exhibition, which fell by 2.14%, 1.70%, and 1.60% respectively [1] Group 2 - The newly rated stocks include Puluo Pharmaceutical with a strong buy rating from Huachuang Securities, and Baolingbao with an increase rating from Guotai Haitong [2] - The target price for Puluo Pharmaceutical is set at 22.00 yuan, while Baolingbao has a target price of 16.30 yuan [2] - Other stocks receiving buy ratings include Miaokelan Duo, Tielong Logistics, and Gole Technology, with target prices of 33.00 yuan, 7.09 yuan, and unspecified respectively [2]

Group 1 - The average stock price of A-shares is 12.39 yuan, with 99 stocks priced over 100 yuan, an increase of 4 from the previous trading day [1] - The Shanghai Composite Index closed at 3605.73 points, up 0.65%, while stocks priced over 100 yuan had an average increase of 1.24%, outperforming the index by 0.58 percentage points [1] - The highest closing price among stocks over 100 yuan is Kweichow Moutai at 1491.50 yuan, up 1.08%, followed by Cambrian and BYD at 600.23 yuan and 342.72 yuan respectively [1] Group 2 - In the past month, stocks priced over 100 yuan have averaged a 12.79% increase, compared to a 6.63% rise in the Shanghai Composite Index [2] - The top performers in this category include Borui Pharmaceutical, New Yisheng, and Jingpin Special Equipment, with increases of 77.87%, 61.07%, and 59.38% respectively [2] - Year-to-date, the average increase for these stocks is 33.45%, outperforming the Shanghai Composite Index by 25.87% [2] Group 3 - The electronic, pharmaceutical, and computer industries are the most concentrated among stocks priced over 100 yuan, with 30.30% from electronics, 15.15% from pharmaceuticals, and 14.14% from computers [2] - Among the stocks priced over 100 yuan, 25 are from the main board, 27 from the ChiNext board, 3 from the Beijing Stock Exchange, and 44 from the Sci-Tech Innovation Board, making up 44.44% of the total [2] - Two stocks, Chip Source Micro and Jinbo Biological, received buy ratings from institutions today, with Chip Source Micro being newly covered [2]

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [5]. Core Views - The company, Xinyuan Micro (芯源微), is a leading domestic manufacturer of large wet processing equipment, focusing on providing comprehensive solutions for semiconductor front-end and back-end equipment and processes. The company has optimized its product layout, forming a product matrix that includes front-end coating and developing equipment, front-end cleaning equipment, back-end advanced packaging equipment, and other small-sized devices [5][8]. - The company has successfully developed various models of front-end coating and developing equipment, achieving coverage of wafer processing for technology nodes of 28nm and above by 2024. The company is also actively seeking client validation for its next-generation ultra-high-capacity coating and developing machine architecture [5][6]. - The company has received substantial orders for its physical cleaning machines and has launched a new chemical cleaning machine that meets high-temperature SPM process requirements, which has been validated by clients and is expected to drive future growth [5][6]. - The recovery of the packaging market is driving high growth in demand for the company's back-end equipment, with continuous orders from domestic and international clients [6][8]. Financial Summary - The company’s revenue is projected to grow from 1,754 million RMB in 2024 to 4,029 million RMB in 2027, with a compound annual growth rate (CAGR) of approximately 38.07% [7]. - The net profit attributable to the parent company is expected to recover from a decline in 2024 to 693 million RMB by 2027, reflecting a significant growth rate of 68.71% [7][11]. - The company’s earnings per share (EPS) is forecasted to increase from 1.01 RMB in 2024 to 3.44 RMB in 2027, indicating strong profitability growth [7][10]. Control and Synergy - Northern Huachuang has gained control over the company, which is expected to inject new momentum into its development. This control is anticipated to enhance collaboration in equipment processes and provide a more comprehensive and efficient solution for clients [8].